Receptor tyrosine kinase inhibitors in cancer.

Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khorram R, Vafadar R, Ghanaatian M, Rezaei-Tazangi F, Baziyar P, Ahmadi A, Hamblin MR, Aref AR.

Open source

DOI: 10.1007/s00018-023-04729-4
Published: 2023-03-22
Container: Cell Mol Life Sci
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00018-023-04729-4,
  title = {Receptor tyrosine kinase inhibitors in cancer.},
  author = {Ebrahimi N and  Fardi E and  Ghaderi H and  Palizdar S and  Khorram R and  Vafadar R and  Ghanaatian M and  Rezaei-Tazangi F and  Baziyar P and  Ahmadi A and  Hamblin MR and  Aref AR.},
  year = {2023},
  journal = {Cell Mol Life Sci},
  doi = {10.1007/s00018-023-04729-4},
  url = {https://doi.org/10.1007/s00018-023-04729-4}
}

RIS

TY  - JOUR
TI  - Receptor tyrosine kinase inhibitors in cancer.
AU  - Ebrahimi N
AU  -  Fardi E
AU  -  Ghaderi H
AU  -  Palizdar S
AU  -  Khorram R
AU  -  Vafadar R
AU  -  Ghanaatian M
AU  -  Rezaei-Tazangi F
AU  -  Baziyar P
AU  -  Ahmadi A
AU  -  Hamblin MR
AU  -  Aref AR.
PY  - 2023
JO  - Cell Mol Life Sci
DO  - 10.1007/s00018-023-04729-4
UR  - https://doi.org/10.1007/s00018-023-04729-4
ER  -

APA

N, E., E, F., H, G., S, P., R, K., R, V., M, G., F, R., P, B., A, A., MR, H., & AR., A. (2023). Receptor tyrosine kinase inhibitors in cancer.. Cell Mol Life Sci. https://doi.org/10.1007/s00018-023-04729-4

Source records

europe-pmc · retrieved 2026-09-27T11:03:51.041Z